Home Yang He, CEO of Vymed Healthcare, to Speak at the 3rd International Medical Device Innovation Summit Amid IPO Filing

Yang He, CEO of Vymed Healthcare, to Speak at the 3rd International Medical Device Innovation Summit Amid IPO Filing

Jun 03, 2021 09:40 CST Updated 09:40

In the fields of in vitro diagnostics, high-value consumables, and rehabilitation equipment, how can the right development path be identified through upstream-downstream supply chain collaboration, upgrading of technological and industrial foundations, and coordinated integration of key industry development factors?June 22, 20212021 3rd International Summit on Medical Device Innovationwill be held onChina · Nanjingheld. This event will center on“Intelligent Manufacturing as the Foundation, Collaborative Innovation”Centered on the theme, this offline summit for the medical device industry will bring together the most active domestic and international medical device innovators, listed companies, financial institutions, and healthcare providers through formats such as the Medical Device Vitality Ranking, closed-door government-enterprise meetings, overseas live connections, keynote speeches, and pioneer dialogues.


This event is hosted by the Nanjing New Medicine and Life Health Industry Chain Task Force and the People's Government of Gaochun District, Nanjing; organized by the Office of the Innovation Committee of the CPC Gaochun District Committee and VCBeat; and co-organized by Jiangsu Gaochun Economic Development Zone and Jiangsu Gaochun High-Tech Industrial Development Zone.


Yang He, CEO of Weimai MedicalConfirmed participation in the 3rd International Summit on Medical Device Innovation, where a related presentation will be delivered.


杨区确定版.jpg

Click the image to register


About Yang He

杨贺.jpg

Yang He, CEO of Weimai Medical


Yang He, Co-founder and CEO of Vmai Medical, brings twenty years of experience in the high-end medical imaging industry and extensive international operational expertise. Previously, he served at TCL Medical Group as R&D Director and General Manager of the Interventional Business Unit. He also held positions at GE Healthcare, including Principal Engineer for Product Lines and R&D Manager, where he gained substantial experience in managing large-scale projects and corporate operations. Mr. Yang holds a bachelor’s degree in Electronics from Peking University and a master’s degree from the Chinese Academy of Sciences. He currently serves as Vice Chairman of the Interventional Professional Committee of the China Association for Popularization of Medical Science, and as a Director of both the China Association of Medical Equipment and the China Medical Devices Industry Association.


Vimai Medical, established in 2014, is a national high-tech enterprise dedicated to the full-process management of interventional imaging. In the field of interventional imaging, Vimai Medical provides an integrated “eye-hand-brain” solution for the entire interventional workflow. The company has built multiple interventional product lines, including large-scale Digital Subtraction Angiography (DSA) systems, mobile angiography units (mid-sized C-arms), surgical C-arms (small C-arms), and interventional surgical robots, achieving technological synergy across these platforms. Currently, China’s interventional industry is experiencing rapid development, with structural changes occurring throughout the industrial ecosystem. Domestic substitution of interventional consumables has remained a key industry focus, giving rise to several publicly listed companies. Today, as the “infrastructure” supporting the growth of the interventional market, domestic interventional imaging solutions are also gradually rising in prominence. As the leading provider of domestically produced DSA equipment, Vimai Medical has spent five years evolving from breakthroughs in single products to a comprehensive portfolio layout, thereby meeting the diversified and differentiated demands for interventional imaging across various clinical scenarios in China.


In China’s vast interventional market, the explosive growth of cardiovascular interventional consumables is just the beginning; next, interventional departments will also demand higher standards for basic equipment.Yang He, Weimai MedicalVCBeatAttended the 3rd International Summit on Medical Device Innovation and delivered a related presentation.

Industry Leaders Convene to Discuss the Future of Medical Devices


1
In-Depth Content: Led by Nobel Laureates and National Academicians

At the summit, we have specially invitedNobel Laureate in Physiology or Medicine, Academician of the Chinese Academy of Sciences and the Chinese Academy of EngineeringDistinguished experts will share cutting-edge technologies and frontier medical advancements from both China and abroad, focusing on medical development amidst technological transformation, and redefining the evolutionary logic of technology and innovative thinking in the industry.


Senior executives from leading medical device companies, distinguished innovative entrepreneurs, seasoned directors of innovation departments, and experienced investors will focus on ““Growth Curve of the IVD Industry in the Post-Pandemic Era,” “High-Value Consumables Under Domestic Substitution and Volume-Based Procurement,” and “Rehabilitation Products and Application Scenario Innovation in an Aging Society”Conduct in-depth discussions along three main lines.


Currently, the 2014 Nobel Prize laureate in Physiology or Medicine,Edvard MoserConfirmed participation in this event, and will deliver a presentation on"How the Brain Works: A Spatial Systems Approach to Decoding Computation in the Brain"Related Shares.Academician of the Chinese Academy of Sciences and neurosurgery expert Zhao Jizong; Academician of the Chinese Academy of Engineering Zhang ZhiyuanAll have confirmed their attendance and will deliver relevant presentations.


2
Future Trends: On-Site Release of Four Regular Top 100 Lists

The 2021 List of Innovative Vitality in Medical Devices is part of the regular series of the Future Healthcare 100. Based on industrial research, VCBeat identifies high-growth innovative medical device companies by focusing on innovation development, technological transformation, and policy updates in the medical device sector.In Vitro Diagnostics (Digital PCR)High-Value Consumables (Cardiovascular Interventional)Rehabilitation Equipment (Rehabilitation Robotics)The rankings across three fundamental dimensions and the “Black Tech” in Medical Devices list selected the 2021 Innovative Vitality Enterprises in the Medical Device Industry.


The 2021 Medical Device Innovation Vitality Ranking will be announced at the 3rd International Summit on Medical Device Innovation in 2021., and will be disseminated and promoted through VCBeat’s online media matrix.


Confirmed Guests (Partial)


Edward Mosol, 2014 Nobel Prize in Physiology or Medicine

Zhao Jizong, Academician of the Chinese Academy of Sciences, Neurosurgeon

Zhang Zhiyuan, Academician of the Chinese Academy of Engineering

Deng Jianmin, Senior Vice President of BD Worldwide and General Manager of Greater China

Kang Keren, Senior Vice President of Wondfo Biotech

Shen Qin, Partner at Shengyu Investment

Guo Feng, Founder of Zhenzhun Bio

Peng Yifei, General Manager of Tigermed Jietong

Jin Lei, CEO of BaiRen Medical

Wang Jinhe, Vice President of Johnson & Johnson MedTech

Yang Zhihao, Vice President of Fourier Intelligence

Xu Junhua, Founder of Aomei Health

More speakers are being confirmed...


Proposed Schedule

议程.png


You’re Just One Ticket Away from Industry Titans


Time:Tuesday, June 22, 2021

Location:China · Nanjing

Conference Official Website:https://vcbeat.top/Forum/summitIndex3


大会官网.png

Click the image above or scan the QR code to register for free